Fresenius Medical Care offers a discounted essential-healthcare turnaround, where dialysis market dominance, cost savings, home therapy growth, and aggressive buybacks could outweigh reimbursement and volume headwinds.
Overview
Fresenius Medical Care is the global leader in dialysis services and renal products, operating 3,539 clinics treating nearly 290,000 patients while holding roughly 40% of the global hemodialysis machine market. Its core Care Delivery, Care Enablement, and Value-Based Care segments create a vertically integrated renal ecosystem with recurring, essential healthcare demand. The U.S. remains the key profit engine, while 5008X technology, home dialysis, and value-based models support a defensible but currently underappreciated turnaround story.